Literature DB >> 33430846

Evaluation of efficacy and safety of percutaneous transforaminal endoscopic surgery (PTES) for surgical treatment of calcified lumbar disc herniation: a retrospective cohort study of 101 patients.

Hao Wang1,2, Tianyao Zhou1,2, Yutong Gu3,4, Zuoqin Yan5.   

Abstract

BACKGROUND: Percutaneous transforaminal endoscopy has been widely used to treat lumbar disc herniation (LDH), but the steep learning curve and difficulties in removing the calcified disc hinders the application of conventional endoscopy in treating calcified lumbar disc herniation (CLDH). In 2017, we first reported Percutaneous Transforaminal Endoscopic Surgery (PTES) as an easy-to-learn posterolateral transforaminal endoscopic technique to decompress the nerve root for LDH. We used our PTES technique to remove the calcified LDH and the purpose of this study is to evaluate the safety and efficacy of this technique.
METHODS: Forty-six patients with CLDH and fifty-five patients with uncalcified lumbar disc herniation (ULDH) underwent PTES to decompress the nerve root. Visual analogue scale was collected before the surgery, immediately, one week, one month, two months, three months, six months, 12 months and 24 months after surgery. The outcomes of MacNab classification were collected 24 months after surgery. Intra- and Post-operative complications were also recorded.
RESULTS: For CLDH patients, the VAS score was 9 (5-10) before operation, and then dropped to 2 (1-4) after surgery. VAS score continually decreased to 0 (0-3) at 24 months after surgery. 95.65% of CLDH patients showed excellent or good outcomes. ULDH group showed similar MacNab classification (94.55%) and VAS changing curve. The therapeutic effect of PTES in treating CLDH was as good as that in treating uncalcified patients.
CONCLUSIONS: PTES is an effective and safe method to treat calcified lumbar disc herniation.

Entities:  

Keywords:  Calcified lumbar disc herniation; Endoscopic discectomy; Minimally invasive surgery; Transforaminal

Mesh:

Year:  2021        PMID: 33430846      PMCID: PMC7802302          DOI: 10.1186/s12891-020-03938-3

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  13 in total

1.  Analysis of hard thoracic herniated discs: review of 18 cases operated by thoracoscopy.

Authors:  Olivier Gille; Christian Soderlund; Henri J C Razafimahandri; Paolo Mangione; Jean-Marc Vital
Journal:  Eur Spine J       Date:  2006-01-12       Impact factor: 3.134

2.  Full Endoscopic Lumbar Discectomy using the Calcification Floating Technique for Symptomatic Partially Calcified Lumbar Herniated Nucleus Pulposus.

Authors:  Hyeun Sung Kim; Nitin Adsul; Yoon Seok Ju; Ki Joon Kim; Sung Ho Choi; Jeong Hoon Kim; Sung Kyun Chung; Jeong-Hoon Choi; Jee-Soo Jang; Il-Tae Jang; Seong-Hoon Oh
Journal:  World Neurosurg       Date:  2018-06-26       Impact factor: 2.104

3.  Percutaneous endoscopic decompression for calcified thoracic disc herniation using a novel T rigid bendable burr.

Authors:  Lei-Ming Zhang; Wen-Ying Lv; Gang Cheng; Deng-Yuan Wang; Jian-Ning Zhang; Xi-Feng Zhang
Journal:  Br J Neurosurg       Date:  2019-01-28       Impact factor: 1.596

4.  Transforaminal Endoscopic Lumbar Discectomy Versus Open Lumbar Microdiscectomy: A Comparative Cohort Study with a 5-Year Follow-Up.

Authors:  Yong Ahn; Sang Gu Lee; Seong Son; Han Joong Keum
Journal:  Pain Physician       Date:  2019-05       Impact factor: 4.965

Review 5.  CLINICAL PRACTICE. Herniated Lumbar Intervertebral Disk.

Authors:  Richard A Deyo; Sohail K Mirza
Journal:  N Engl J Med       Date:  2016-05-05       Impact factor: 91.245

6.  Percutaneous Endoscopic Lumbar Discectomy in Treating Calcified Lumbar Intervertebral Disc Herniation.

Authors:  Yu Chen; Jian-Xi Wang; Bin Sun; Peng Cao; Ye Tian; Xiao-Long Shen; Yang Liu; Hua-Jiang Chen; Xin-Wei Wang; Wen Yuan; Xiao-Dong Wu
Journal:  World Neurosurg       Date:  2018-11-20       Impact factor: 2.104

7.  Transforaminal posterolateral endoscopic discectomy with or without the combination of a low-dose chymopapain: a prospective randomized study in 280 consecutive cases.

Authors:  Thomas Hoogland; Michael Schubert; Boris Miklitz; Agnes Ramirez
Journal:  Spine (Phila Pa 1976)       Date:  2006-11-15       Impact factor: 3.468

Review 8.  Physical examination for lumbar radiculopathy due to disc herniation in patients with low-back pain.

Authors:  Daniëlle Awm van der Windt; Emmanuel Simons; Ingrid I Riphagen; Carlo Ammendolia; Arianne P Verhagen; Mark Laslett; Walter Devillé; Rick A Deyo; Lex M Bouter; Henrica Cw de Vet; Bert Aertgeerts
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

9.  Percutaneous transforaminal endoscopic surgery (PTES) for symptomatic lumbar disc herniation: a surgical technique, outcome, and complications in 209 consecutive cases.

Authors:  Yu-Tong Gu; Zhan Cui; Hong-Wei Shao; Yun Ye; Ai-Qun Gu
Journal:  J Orthop Surg Res       Date:  2017-02-08       Impact factor: 2.359

10.  Circumspinal decompression and fusion through a posterior midline incision to treat central calcified thoracolumbar disc herniation: a minimal 2-year follow-up study with reconstruction CT.

Authors:  Ning Liu; Zhongqiang Chen; Qiang Qi; Weishi Li; Zhaoqing Guo
Journal:  Eur Spine J       Date:  2013-10-05       Impact factor: 3.134

View more
  3 in total

1.  Treatment of Calcified Lumbar Disc Herniation by Intervertebral Foramen Remolding: A Retrospective Study.

Authors:  Ao-Lin Yuan; Xin Shen; Bin Chen
Journal:  J Pain Res       Date:  2022-06-16       Impact factor: 2.832

2.  Percutaneous endoscopic interlaminar discectomy for L5-S1 calcified lumbar disc herniation: A retrospective study.

Authors:  Yuanpei Cheng; Qianru Zhang; Yongbo Li; Xipeng Chen; Han Wu
Journal:  Front Surg       Date:  2022-09-23

3.  A comparative study of percutaneous endoscopic interlaminar discectomy and transforaminal discectomy for L5-S1 calcified lumbar disc herniation.

Authors:  Yuan-Pei Cheng; Xiao-Kang Cheng; Han Wu
Journal:  BMC Musculoskelet Disord       Date:  2022-03-12       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.